January 31, 2020Letter Agreement • February 28th, 2020 • Accelerate Diagnostics, Inc • Laboratory analytical instruments
We are delighted to enter into this Letter Agreement (the “Agreement”) under which you will serve as the Chief Executive Officer of Accelerate Diagnostics, Inc. (the “Company”). Your start date as President and Chief Executive Officer will be February 1, 2020 (“Start Date”). Once this Agreement becomes effective, it will form the entire agreement between you and the Company with respect to the matters described in this Agreement and it will supersede and replace any prior understandings (whether oral or written) with respect to the subject matter described herein, including the letter agreement between you and the Company, dated August 6, 2019.
TRANSITION AGREEMENT, PART-TIME EMPLOYMENT AGREEMENT, AND GENERAL RELEASE OF CLAIMSTransition Agreement • February 28th, 2020 • Accelerate Diagnostics, Inc • Laboratory analytical instruments • Arizona
This TRANSITION AGREEMENT, PART-TIME EMPLOYMENT AGREEMENT, AND GENERAL RELEASE OF CLAIMS (the “Agreement”) is entered into as of December 1, 2019, by and between Accelerate Diagnostics, Inc. (the “Company”), and Lawrence Mehren (“Executive”). The Company and Executive are collectively referred to herein as the Parties.
